Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
Go back to Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant| (NASDAQ: COCH) | Delayed: 0.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.63 | 52 Week High | $ | |||
| Open | $0.63 | 52 Week Low | $ | |||
| Day High | $0.63 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $ | |||
| Volume | 1,192 | |||||
